3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Ovarian High Grade Serous Adenocarcinoma
1
Medulloblastoma
1
Locally Advanced Non-Small Cell Lung Cancer
1
Leukemia, Myeloid, Acute
1
Hypoxia
1
Glioma
1
Diffuse Intrinsic Pontine Glioma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
6
TH 302
4
Radiotherapy
4
pimonidazole
3
fluoroazomycin arabinoside
3
Propofol
3
Injections
3
Positron Emission Tomography Computed Tomography
2
Blood Specimen Collection
2
Bacterial Load
2
pomalidomide
1
pembrolizumab
1
inositol trispyrophosphate
1
gadobutrol
1
fluoromisonidazole
1
fludarabine
1
Tirapazamine
1
Temozolomide
1
Sodium Chloride
1
Sevoflurane
1
Saline Solution
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Oxygen
1
Nitroglycerin
1
Nimorazole
1
NVP-BKM120
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Ketamine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hypoxia
×
Atovaquone
×
Clear all
NCT02628080
2019-09-04
ATOM
University of Oxford
Phase EARLY_PHASE1
Completed
46 enrolled